Influenza, Human: Clinical Trials

2,166 trials for Influenza, Human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1690 completed, 140 unknown, 104 recruiting, 76 terminated. 493 Phase 2, 430 Phase 3, 395 Phase 1, 347 Phase 4, 330 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 2493Completed 413, Withdrawn 20, Terminated 18, Recruiting 15, Unknown 15, Not yet recruiting 7, Active not recruiting 5
Phase 3430Completed 356, Recruiting 19, Unknown 17, Terminated 13, Withdrawn 10, Not yet recruiting 7, Active not recruiting 4, Suspended 4
Phase 1395Completed 333, Recruiting 16, Unknown 13, Withdrawn 13, Terminated 9, Active not recruiting 7, Not yet recruiting 3, Enrolling by invitation 1
Phase 4347Completed 267, Unknown 30, Terminated 15, Recruiting 12, Active not recruiting 10, Not yet recruiting 7, Withdrawn 4, Enrolling by invitation 1, Suspended 1
Not applicable330Completed 236, Unknown 28, Recruiting 19, Not yet recruiting 14, Terminated 13, Active not recruiting 9, Withdrawn 6, Enrolling by invitation 5
Early Phase 17Completed 5, Active not recruiting 1, Not yet recruiting 1

Follow Influenza, Human: new trials by email Literature Review of Influenza, Human trials Research Report on Influenza, Human

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates
cH15/3, cH4/3, cH5/1N1 - Influenza
Phase 1Not yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)602026-12-112026-11-13
How Healthy Adults Respond to the Nasal Flu Vaccine
FluMist (Live Attenuated Influenza Vaccine) - Mucosal Immune Response to Influenza Vaccination
Phase 4Not yet recruitingUniversity of Alabama at Birmingham202026-12-012026-10-13
A Human Influenza Transmission Study Using Naturally Infected Community Donors
Influenza Donor Visit, Influenza Recipient Inpatient Exposures Sessions - Influenza
Not applicableNot yet recruitingEmory University1502026-12-012026-09-11
Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS
AVM0703, Placebo - ARDS, Covid19
Phase 1Not yet recruitingAVM Biotechnology Inc162026-12-012026-11-02
Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections
Baseline MxA testing, Serial MxA testing, MxA result feedback and antiviral treatment recommendations - Respiratory Viral Infections, Influenza
Not applicableNot yet recruitingCapital Medical University6182026-11-302026-10-23
BPL-1357 Against H1N1 Influenza Virus Challenge
BPL-1357 IM, BPL-1357 IN, Placebo IM - Influenza, Human
Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)1292026-11-192026-11-16
A Trial of RLX-2508-102 in Healthy Volunteers
RLX-2508 - Influenza
Early Phase 1Not yet recruitingAtridia Pty Ltd.1012026-11-152026-10-14
High-Dose Versus Standard-Dose Influenza Vaccine in Patients With Hematologic Malignancies Receiving B-Cell-Depleting Therapy
High-dose inactivated influenza vaccine, Standard-dose inactivated influenza vaccine - Hematologic Malignancy, Influenza
Phase 2RecruitingSung-Han Kim602026-11-022026-11-09
Preoperative Pneumococcal and Influenza Vaccination to Prevent Postoperative Pulmonary Infection in Patients Undergoing Lung Resection for Pulmonary Nodules or Lung Cancer
23-valent pneumococcal polysaccharide vaccine, Quadrivalent split-virion influenza vaccine - Pneumococcal Polysaccharide Vaccine, Influenza Vaccines
Phase 4Not yet recruitingThe First Affiliated Hospital of Guangzhou Medical University12782026-11-012026-10-21
Immunogenicity of Standard-Dose Versus High-Dose Influenza Vaccines in Older Adults in Singapore
High-dose influenza vaccine, Standard-dose influenza vaccine - Influenza
Phase 4Not yet recruitingTan Tock Seng Hospital1502026-11-012026-10-20
Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France Region
Vaccination Coverage Among Pregnant Women
Not yet recruitingAssistance Publique - Hôpitaux de Paris16052026-11-012026-10-20
Personalized Ventilator Settings for Patients on ECMO
Personalized Positive End-Expiratory Pressure (PEEP) - Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Not applicableEnrolling by invitationUniversity of California, San Diego622026-11-012026-11-06
Study of a Combination SARS-CoV-2 Recombinant Spike and High-Dose Inactivated Influenza Vaccine With Matrix-M Adjuvant in Adult Participants 60 Years of Age and Older
IIV-HD (standalone), NVXC19 (EU licensed, standalone), IIV-HD + NVXC19 combination - Immunization, Healthy Volunteers
Phase 3RecruitingSanofi60002026-10-282026-11-13
Family Physician Nudges for Influenza Vaccination Among Older Adults
Family Physician Influenza Vaccination Nudge - Influenza Vaccination
Not applicableNot yet recruitingFudan University30602026-10-242026-10-26
Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza
20 mg 102D-6 dry suspension, 40 mg 102D-6 dry suspension, Placebo - Influenza, Human
Phase 2 / Phase 3Not yet recruitingCapital Medical University5702026-10-212026-10-26
Conversational AI for Adult Flu Vaccination Decisions
Flu vaccination guide, Accident safety guide - Influenza, Human, Vaccine Hesitancy
Not applicableActive not recruitingCalypta Systems, Inc.2202026-10-212026-11-04
A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants
Baloxavir marboxil, Placebo - Influenza, Human, Respiratory Tract Infections
Phase 3RecruitingHoffmann-La Roche3252026-10-162026-10-22
Sequential Digital Intervention to Increase Influenza Vaccination in Patients With Heart Failure
Routine Influenza Vaccination Recommendation, Repeated AI-Assisted Telephone Intervention, Gain-Framed SMS Reminder - Heart Failure, Influenza Vaccination
Not applicableNot yet recruitingHeart Health Research Center5882026-10-152026-10-19
SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluster Randomized Trial)
LAIV FLUMIST - Influenza (Healthy Volunteers)
Phase 4Not yet recruitingMcMaster University9662026-10-152026-07-31
A Study of Updated mRNA Seasonal Influenza Vaccines
mRNA-1010, Licensed High-Dose Seasonal Influenza Vaccine - Seasonal Influenza
Phase 4RecruitingModernaTX, Inc.2002026-10-152026-11-13

Showing 20 of 2166. Sign in to see all of them.

Narrower conditions

COVID-19 (114)  ·  Virus Diseases (97)  ·  Respiratory Tract Infections (88)  ·  Orthomyxoviridae Infections (72)  ·  Influenza in Birds (68)  ·  Infections (53)  ·  Common Cold (47)  ·  Pneumonia (34)  ·  Respiratory Tract Diseases (26)  ·  Coronavirus Infections (20)  ·  RNA Virus Infections (20)  ·  Respiratory Syncytial Virus Infections (17)  ·  Whooping Cough (16)  ·  HIV Infections (15)

Broader conditions

RNA Virus Infections (2146)  ·  Respiratory Tract Diseases (2140)  ·  Infections (2113)  ·  Orthomyxoviridae Infections (2094)  ·  Respiratory Tract Infections (2078)  ·  Virus Diseases (2069)  ·  Lung Diseases (171)  ·  Coronaviridae Infections (127)  ·  Nidovirales Infections (127)  ·  Pneumonia (123)  ·  Pathological Conditions, Signs and Symptoms (121)  ·  Pneumonia, Viral (113)  ·  Coronavirus Infections (107)  ·  Pathologic Processes (87)  ·  Animal Diseases (68)

Interventions

Influenza Vaccines (424)  ·  Oseltamivir (86)  ·  FluMist (60)  ·  fluarix (52)  ·  vaxigrip (47)  ·  Vaccines (33)  ·  Sodium Chloride (31)  ·  baloxavir (22)  ·  fluad vaccine (21)  ·  Fluzone High-Dose (16)  ·  FluBlok (15)  ·  Saline Solution (15)  ·  Zanamivir (14)  ·  Adjuvants, Pharmaceutic (13)  ·  mRNA-1010 influenza vaccine (13)

Sponsors

GlaxoSmithKline (184)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (173)  ·  Sanofi Pasteur, a Sanofi Company (116)  ·  Novartis Vaccines (59)  ·  Seqirus (51)  ·  MedImmune LLC (41)  ·  Stanford University (29)  ·  Alachua Government Services, Inc. (24)  ·  Novartis (24)  ·  ModernaTX, Inc. (22)  ·  Sanofi (22)  ·  Hoffmann-La Roche (20)  ·  Crucell Holland BV (18)  ·  The University of Hong Kong (18)  ·  Sinovac Biotech Co., Ltd (17)

Countries

United States (915)  ·  Canada (148)  ·  China (139)  ·  United Kingdom (137)  ·  Germany (108)  ·  France (95)  ·  Belgium (92)  ·  Australia (83)  ·  Russia (62)  ·  Spain (59)  ·  South Korea (54)  ·  Poland (50)  ·  Italy (45)  ·  Taiwan (44)  ·  Thailand (44)

Top investigators

Robert Walker, MD (16)  ·  Cornelia Dekker, MD (14)  ·  Matthew J Memoli, M.D. (10)  ·  Melissa Stockwell, MD MPH (8)  ·  Stephen Quake, PhD (8)  ·  Xiaosong He, PhD (8)

Results publications

PMID 28963118, PMID 33215698, PMID 36715243, PMID 39756216, PMID 19261173, PMID 21857263, PMID 26432909, PMID 26787832, PMID 28325769, PMID 29443825, PMID 29465480, PMID 29706550, PMID 30066805, PMID 32379201, PMID 32526188, PMID 39550717, PMID 42834081, PMID 18420314, PMID 18599164, PMID 19540952, PMID 19588665, PMID 20018364, PMID 20018365, PMID 21352939, PMID 21378375, PMID 21615847, PMID 21906647, PMID 22172502, PMID 22418809, PMID 22537984, PMID 22542645, PMID 22872731, PMID 22885014, PMID 22906937, PMID 24041010, PMID 24606983, PMID 25004134, PMID 25148380, PMID 25184864, PMID 25222307, PMID 26042486, PMID 26069949, PMID 26176592, PMID 26275339, PMID 26391974, PMID 27746226, PMID 28369198, PMID 28446441, PMID 29100706, PMID 29253090

NIH funding

2009 (23), U19AI057229 (20), 2008 (12), 2015 (10), 2016 (8), 2018 (7), R01AI135029 (7), 2023 (6), 2014 (5), P30AG034532 (5), 2025 (4), U19AI090019 (4), 2017 (3), 2019 (3), N01AI30025 (3)